Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells

Leukemia

Volumn 10, Issue 4, 1996, Pages 588-599

  Drexler, H G ^a  

^a LEIBNIZ INSTITUTE DSMZ GERMAN COLLECTION OF MICROORGANISMS AND CELL CULTURES   (Germany)

Author keywords

FLT3; FLT3 ligand; Leukemia; Receptor tyrosine kinase

Indexed keywords

COLONY STIMULATING FACTOR; COLONY STIMULATING FACTOR 1; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR RECEPTOR; HEMOPOIETIC GROWTH FACTOR; INTERLEUKIN 11; INTERLEUKIN 12; INTERLEUKIN 3; INTERLEUKIN 6; INTERLEUKIN 7; STEM CELL FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; BLAST CELL CRISIS; BONE MARROW; CHRONIC MYELOID LEUKEMIA; DNA SYNTHESIS; FAMILY; FETUS LIVER; FLOW CYTOMETRY; GENE EXPRESSION; HEMATOPOIESIS; HEMATOPOIETIC CELL; HEMATOPOIETIC STEM CELL; HUMAN; LEUKEMIA; LEUKEMIA CELL LINE; LIGAND BINDING; MOUSE; NONHUMAN; PATHOLOGY; PRE B LYMPHOCYTE; PRIORITY JOURNAL; RECEPTOR GENE; REVIEW; T CELL LEUKEMIA;

EID: 0030002950     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (118)

1. Clark SC, Kamen R. The human hematopoietic colony-stimulating factors. Science 1987; 236: 1229-1237.
2. Metcalf D. The molecular control of cell division, differentiation commitment and maturation in haemopoietic cells. Nature 1989; 339: 27-30.
3. Nicola NA. Hemopoietic cell growth factors and their receptors. Annu Rev Biochem 1989; 58: 45-77.
4. Löwenberg B, Touw I. Hematopoietic growth factors and their receptors in acute leukemia. Blood 1993; 81: 281-292.
5. Ogawa M. Differentiation and proliferation of hematopoietic stem cells. Blood 1993; 81: 2844-2853.
6. Callard R, Gearing A (eds). The Cytokine FactsBook. Academic Press: London, 1994.
7. Nicola NA (ed). Guidebook to Cytokines and their Receptors. Oxford University Press: Oxford, 1994.
8. Belka C, Brach MA, Herrmann F. The role of tyrosine kinases and their substrates in signal transmission of hematopoietic growth factors: a short review Leukemia 1995; 9: 754-761.
9. Budel LM, Dong F, Lowenberg B, Touw IP. Hematopoietic growth factor receptors: structure variations and alternatives of receptor complex formation in normal hematopoiesis and in hematopoietic disorders. Leukemia 1995; 9: 553-561
10. Ullrich A, Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell 1990; 61: 203-212.
11. Metcalf D. Hematopoietic regulators: redundancy or subtlety? Blood 1993, 82: 3515-3523.
12. Karnitz LM, Abraham RT. Cytokine receptor signaling mechanisms. Curr Opin Immunol 1995; 7: 320-326.
13. Ihle JN, Witthuhn BA, Quelle FW, Yamamoto K, Thierfelder WE, Kreider B, Silvennoinen O. Signalling by the cytokine receptor superfamily: JAKs and STATs. Trends Biochem Sci 1994; 19: 222-227.
14. Bazan JF Haematopoietic receptors and helical cytokines. Immunol Today 1990; 11: 350-354.
15. Cosman D, Lyman SD, Idzerda RL, Beckmann MP, Park LS, Goodwin RG, March CJ. A new cytokine receptor superfamily. Trends Biochem Sci 1990; 15: 265-269.
16. Cosman D. The hematopoietin receptor superfamily Cytokine 1993; 5: 95-106.
17. Hanks S, Quinn AM, Hunter T. The protein kinase family conserved features and deduced phylogeny of the catalytic domains. Science 1988; 241: 42-52.
18. Rosnet O, Birnbaum D. Haematopoietic receptors of class III receptor-type tyrosine kinases. Crit Rev Oncogen 1993; 4: 595-613.
19. Cadena DL, Gill GN. Receptor tyrosine kinases. FASEB J 1992; 6: 2332-2337.
20. Yarden Y, Ullrich A. Growth factor receptor tyrosine kinases. Annu Rev Biochem 1988; 57: 443-478.
21. Sherr CJ. Colony-stimulating factor-1 receptor. Blood 1990; 75: 1-12.
22. Bazan JF. Genetic and structural homology of stem cell factor and macrophage colony-stimulating factor. Cell 1991; 65: 9-10.
23. Williams DE, Lyman SD. Characterization of the gene product of the Steel locus. Prog Growth Factor Res 1992; 3: 235-242.
24. Galli SJ, Szebo KM, Geissler EN. The kit ligand, stem cell factor. Adv Immunol 1994; 55: 1-96.
25. Matthews W, Jordan CT, Wiegand GW, Pardoll D, Lemischka IR. A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populations. Cell 1991; 65: 1143-1152.
26. Rosnet O, Marchetto S, de Lapeyriere O, Birnbaum D. Murine Flt3, a gene encoding a novel tyrosine kinase receptor of the PDGFR/CSF1R family. Oncogene 1991; 6: 1641-1650.
27. Rosnet O, Mattei MG, Marchetto S, Birnbaum D. Isolation and chromosomal localization of a novel FMS-like tyrosine kinase gene. Genomics 1991; 9: 380-385.
28. Rosnet O, Schiff C, Pébusque MJ, Marchetto S, Tonnelle C, Toiron Y, Birg F, Birnbaum D. Human FLT3/FLK2 gene: cDNA cloning and expression in hematopoietic cells. Blood 1993; 82: 1110-1119.
29. Lyman SD, James L, Zappone J, Sleath PR, Beckmann MP, Bird T. Characterization of the protein encoded by the flt3 (flk2) receptor-like tyrosine kinase gene. Oncogene 1993; 8: 815-822.
30. Small D, Levenstein M, Kim E, Carow C, Amin S, Rockwell P, Witte L, Burrow C, Ratajczak MZ, Gewirtz AM, Civin CI. STK-1, the human homolog of Flk-2/Flt-3, is selectively expressed in CD34+ human bone marrow cells and is involved in the proliteration of early progenitor stem cells. Proc Natl Acad Sci USA 1993; 91: 459-463.
31. Agnès F, Shamoon B, Dina C, Rosnet O, Birnbaum D, Galibert F. Genomic structure of the downstream part of the human FLT3 gene: exon/intron structure conservation among genes encoding receptor tyrosine kinases (RTK) of subclass III. Gene 1994; 145: 283-288.
32. Aprelikova O, Pajusola K, Partanen J, Armstrong E, Alitalo R, Bailey S, McMahon I, Wasmuth J, Alitalo K. FLT4, a novel class III receptor tyrosine kinase in chromosome 5q33-qter. Cancer Res 1992; 52: 746-748.
33. Galland F, Karamysheva A, Mattéi MG, Rosnet O, Marchetto S, Birnbaum D. Chromosomal localization of FLT4, a novel receptor-type tyrosine kinase gene. Genomics 1992; 13: 475-478.
34. Galland F, Karamysheva A, Pebusque MJ, Borg JP, Rottapel R, Dubreuil P, Rosnet O, Birnbaum D. The FLT4 gene encodes a transmembrane tyrosine kinase related to the vascular endothelial growth factor receptor. Oncogene 1993; 8: 1233-1240.
35. Matthews W, Jordan CT, Gavin M, Jenkins NA, Copeland NG, Lemischka IR. A receptor tyrosine kinase cDNA from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit. Proc Natl Acad Sci USA 1991; 88: 9026-9030.
36. Pajusola L, Aprelikova O, Korhonen J, Kalpainen A, Pertovaara L, Alitalo R, Alitalo K. FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines. Cancer Res 1992; 52: 5738-5743.
37. Shibuya M, Yamaguchi S, Yamane A, Ikeda T, Tojo A, Matsushime H, Sato M. Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family. Oncogene 1990; 5: 519-524.
38. Iwama A, Okano K, Sudo T, Matsuda Y, Suda T. Molecular cloning of a novel receptor tyrosine kinase gene, STK, derived from enriched hematopoietic stem cells. Blood 1994; 83: 3160-3169.
39. Rosnet O, Stephenson D, Mattei MG, Marchetto S, Shibuya M, Chapman VM, Birnbaum D. Close physical linkage of the FLT1 and FLT3 genes on chromosome 13 in man and chromosome 5 in mouse. Oncogene 1993; 8: 173-179.
40. Imbert A, Rosnet O, Marchetto S, Ollendorf V, Birnbaum D, Pebusque MJ. Characterization of a yeast artificial chromosome from human chromosome band 13q12 containing the flt1 and flt3 receptor-type tyrosine kinase genes. Cytogenet Cell Genet 1994; 67: 175-177.
41. Carow CE, Kim E, Hawkins AL, Webb HD, Griffin CA, Jabs EW, Civin CI, Small D. Localization of the human stem cell tyrosine kinase-1 gene (FLT3) to 13q12-q13. Cytogenet Cell Genet 1995; 70: 255-257.
42. Lavagna C, Marchetto S, Birnbaum D, Rosnet O. Identification and characterization of a functional murine FLT3 isoform produced by exon skipping. J Biol Chem 1995; 270: 3165-3171.
43. Maroc N, Rottapel R, Rosnet O, Marchetto S, Lavezzi C, Mannoni P, Birnbaum D, Dubreuil P. Biochemical characterization and analysis of the transforming potential of the FLT3/FLK2 receptor tyrosine kinase. Oncogene 1993; 8: 909-918.
44. Ito A, Hirota S, Kitamura Y, Nomura S. Developmental expression of flt3 mRNA in the mouse brain. J Mol Neurosci 1994; 4: 235-243.
45. De Lapeyrière O, Naquet P, Planche J, Marchetto S, Rottapel R, Gambarelli D, Rosnet O, Birnbaum D. Expression of Flt3 tyrosine kinase receptor gene in mouse hematopoietic and nervous tissues. Differentiation 1995; 5: 351-359.
46. Rasko JEJ, Metcalf D, Rossner MT, Begley CG, Nicola NA. The flt3/flk-2 ligand: receptor distribution and action on murine haemopoietic cell survival and proliferation. Leukemia 1995; 9: 2058-2066.
47. Lyman SD, Brasel K, Rousseau AM, Williams DE. The flt3 ligand: a hematopoietic stem cell factor whose activities are distinct from Steel factor. Stem Cells 1994; 12 (Suppl. 1): 99-110.
48. Lyman SD. Biology of flt3 ligand and receptor. Int J Hematol 1995; 62: 63-73.
49. Lyman SD, Williams DE. Biology and potential clinical appli cations of flt3 ligand. Curr Opin Hematol 1995; 2: 177-181.
50. Rosnet O, Buhring HJ, de Lapeyrière O, Beslu N, Lavagna C, Marchetto S, Rappold I, Drexler HG, Birg F, Rottapel R, Hannum C, Dubreuil P, Birnbaum D. Expression and signal transduction of the FLT3 tyrosine kinase receptor. Acta Haematol 1996 (in press).
51. McKenna H, de Vries P, Brasel K, Lyman SD, Williams DE Effect of flt3 ligand on the ex vivo expansion of human CD34+ hematopoietic progenitor cells. Blood 1995; 86: 3413-3420.
52. Gabbianelii M, Pelosi E, Montesoro E, Valtieri M, Luchetti L, Samoggia P, Vitelli L, Barberi T, Testa U, Lyman S, Peschle C. Multi-level effects of flt3 ligand on human hematopoiesis: expansion of putative stem cells and proliferation of granulomonocytic progenitors/monocytic precursors. Blood 1995; 86: 1661-1670.
53. Dosil M, Wang S, Lemischka IR. Mitogenic signalling and substrate specificity of the Flk2/Flt3 receptor tyrosine kinase in fibroblasts and interleukin 3-dependent hematopoietic cells. Mol Cell Biol 1993; 13: 6572-6585.
54. Rottapel R, Turck CW, Casteran N, Liu X, Birnbaum D, Pawson T, Dubreuil P. Substrate specificities and identification of a putative binding site for PI3K in the carboxy tail of the murine Flt3 receptor tyrosine kinase. Oncogene 1994; 9: 1755-1765.
55. Zeigler FC, Bennett BD, Jordan CT, Spencer SD, Baumhueter S, Carroll KJ, Hooley J, Bauer K, Matthews W. Cellular and molecular characterization of the role of the FLK-2/FLT-3 receptor tyrosine kinase in hematopoietic stem cells. Blood 1994; 8: 2422-2430.
56. Rossner MT, McArthur GA, Allen JD, Metcalf D. Fms-like tyrosine kinase 3 catalytic domain can transduce a proliterative signal in FDC-P1 cells that is qualitatively similar to the signal delivered by c-fms. Cell Growth Differ 1994; 5: 549-555.
57. Casteran D, Rottapel R, Beslu N, Lecocq E, Birnbaum D, Dubreuil P. Analysis of the mitogenic pathway of the FLT3 receptor and characterization in its C terminal region of a specific binding site for the PI3′ kinase. Cell Mol Biol 1994; 40: 443-456.
58. Mackarehtschian K, Hardin JD, Moore KA, Boast S, Goff SP, Lemischka IR. Targeted disruption of the flk2/flt3 gene leads to deficiencies in primitive hematopoietic progenitors. Immunity 1995; 3: 147-161.
59. Lyman SD, James L, Vanden Bos T, De Vries P, Brasel K, Gliniak B, Hollingsworth LT, Picha KS, McKenna HJ, Splett RR, Fletcher FA, Maraskovsky E, Farrah T, Foxworthe D, Williams DE, Beckmann MP. Molecular cloning of a ligand for the flt3/flk-2 tyrosine kinase receptor: A proliferative factor for primitive hematopoietic cells. Cell 1993; 75: 1157-1167.
60. Hannum C, Culpepper J, Campbell D, McClanahan T, Zurawski S, Bazan JF, Kastelein R, Hudak S, Wagner J, Mattson J, Luh J, Duda G, Martina N, Peterson D, Menon S, Shanafelt A, Muench M, Keiner G, Namikawa R, Rennick D, Roncarolo MG, Zlotnik A, Rosnet O, Dubreuil P, Birnbaum D, Lee F. Ligand for FLT3/FLK2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant RNAs. Nature 1994; 368. 643-648.
61. Lyman SD, James L, Johnson L, Brasel K, de Vries P, Escobar SS, Downey H, Splett RR, Beckmann MP, McKenna HJ. Cloning of the human homologue of the murine flt3 ligand: a growth factor for early hematopoietic progenitor cells. Blood 1994; 83: 2795-2801.
62. Lyman SD, James L, Escobar SS, Downey H, de Vries P, Brasel K, Stocking K, Beckmann MP, Copeland NG, Cleveland LS, Jenkins NA, Davison B. Identification of a soluble and membrane bound isoforms of the murine flt3 ligand generated by alternative splicing of mRNAs. Oncogene 1995; 10: 149-159.
63. Lyman SD, Stocking K, Davison B, Fletcher F, Johnson L, Escobar S. Structural analysis of human and murine flt3 ligand genomic loci. Oncogene 1995; 11: 1165-1172.
64. Hudak S, Hunte B, Culpepper J, Menon S, Hannum C, Thompson-Snipes L, Rennick D. FLT3/FLK2 ligand promotes the growth of murine stem cells and the expansion of colony-forming cells and spleen colony-forming units. Blood 1995; 85: 2747-2755.
65. Jacobsen SEW, Okkenhaug C, Myklebust J, Velby OP, Lyman SD. The FLT3 ligand potently and directly stimulates the growth and expansion of primitive murine bone marrow progenitor cells in vitro: synergistic interactions with interleukin (IL) 11, IL-12, and other hematopoietic growth factors. J Exp Med 1995; 181: 1357-1363.
66. Hirayama F, Lyman SD, Clark SC, Ogawa M. The flt3 ligand supports proliferation of lymphohematopoietic progenitors and early B-lymphoid progenitors. Blood 1995; 85: 1762-1768.
67. Broxmeyer HE, Lu L, Cooper S, Ruggieri L, Li ZH, Lyman SD. Flt3 ligand stimulates/costimulates the growth of myeloid stem/progenitor cells. Exp Hematol 1995; 23: 1121-1129.
68. Muench MO, Roncarolo MG, Menon S, Xu Y, Kastelein R, Zurawski S, Hannum CH, Culpepper J, Lee F, Namikawa R. FLK-2/FLT-3 ligand regulates the growth of early myeloid progenitors isolated from human fetal liver. Blood 1995; 85: 963-972.
69. Piacibello W, Fubini L, Sanavio F, Brizzi MF, Severino A, Garetto L, Stacchini A, Pegoraro L, Aglietta M. Effects of human FLT3 ligand on myeloid leukemia cell growth: heterogeneity in response and synergy with other hematopoietic growth factors. Blood 1995; 86: 4105-4114.
70. Lyman SD, Seaberg M, Hanna R, Zappone J, Brasel K, Abkowitz JL, Prchal JT, Schutz JC, Shahidi NT. Plasma/serum levels of flt3 ligand are low in normal individuals and highly elevated in patients with Fanconi anemia and acquired aplastic anemia. Blood 1995; 86: 4091-4096.
71. Scopes J, Daly S, Ball SE, McGuckin CP, Gordon-Smith EC, Gibson FM. The effect of human flt-3 ligand on committed progenitor cell production from normal, aplastic anaemia and Diamond-Blacktan anaemia bone marrow. Br J Haematol 1995; 91: 544-550.
72. Birg F, Courcoul M, Rosnet O, Bardin f, Pébusque MJ, Marchetto S, Tabilio A, Mannoni P, Birnbaum D. Expression of the FMS/KIT-like gene FLT3 in human acute leukemias of the myeloid and lymphoid lineages. Blood 1992; 80: 2584-2593.
73. Rappold I, Rosnet O, Birnbaum D, Kanz L, Bühring HJ. The FLT3/FLK2 receptor tyrosine kinase is a cell surface protein expressed on defined subsets of normal human bone marrow cells and on leukemic blasts from patients with ALL and AML. Blood 1995; 86: 145a.
74. Rosnet O, Buhring HJ, Marchetto S, Rappold I, Lavagna C, Sainty D, Arnoulet C, Chabannon C, Kanz L, Hannum C, Birnbaum D. The human FLT3/FLK2 hematopoietic receptor tyrosine kinase is expressed at the surface of normal and malignant hematopoietic cells. Leukemia 1996; 10: 238-248.
75. Schwinzer B, Schrappe M, Bühring HJ, Reiter A, Wittner N, Riehm HJ, Weite K. Expression of receptor tyrosine kinase on lymphoblasts is related to the risk for relapse in childhood acute lymphoblastic leukemia. Blood 1995; 86: 176a.
76. Eder M, Hemmati P, Kalina U, Ottmann OG, Hoelzer D, Lyman SD, Ganser A. Effects of FLT3-ligand and interleukin-7 on in-vitro growth of acute lymphoblastic leukemia cells. Exp Hematol (in press).
77. McKenna HJ, Smith FO, Brasel K, Hirschstein D, Bernstein ID, Williams DE, Lyman SD. The effects of flt3 ligand on acute myeloid and lymphocytic leukemic blast cells from children. Exp Hematol 1996; 24: 378-385.
78. Dehmel U, Zaborski M, Meierhoff G, Rosnet O, Birnbaum D, Ludwig WD, Quentmeier H, Drexler HG. Effects of FLT3 ligand on human leukemia cells. I. Proliferative response of myeloid leukemia cells. Leukemia 1996; 10: 261-270.
79. Birg F, Rosnet O, Carbuccia N, Birnbaum D. The expression of FMS, KIT and FLT3 in hematopoietic malignancies. Leuk Lymphoma 1994; 13: 223-227.
80. Rose C, Rockwell P, Yang JQ, Pytowski B, Goldstein NI. Isolation and characterization of a monoclonal antibody binding to the extracellular domain of the flk-2 tyrosine kinase receptor. Hybridoma 1995; 14: 453-459.
81. DaSilva N, Hu ZB, Ma W, Rosnet O, Birnbaum D, Drexler HG. Expression of the FLT3 gene in human leukemia-lymphoma cell lines. Leukemia 1994; 8: 885-888.
82. Meierhoff G, Dehmel U, Gruss HJ, Rosnet O, Birnbaum D, Quentmeier H, Dirks W, Drexler HG. Expression of FLT3 receptor and FLT3-ligand in human leukemia-lymphoma cell lines. Leukemia 1995; 9: 1368-1372.
83. Brasel K, Escobar S, Anderberg R, de Vries P, Gruss HJ, Lyman SD. Expression of the flt3 receptor and its ligand on hematopoietic cells. Leukemia 1995, 9: 1212-1218.
84. Dehmel U, Quentmeier H, Drexler HG. Effects of FLT3 ligand on human leukemia cells. II. Agonistic and antagonistic effects of other cytokines. Leukemia 1996; 10: 271-278.
85. Uphoff CC, Hu ZB, Gignac SM, Ma W, Rainey FA, Kreutz M, Ludwig WD, Drexler HG. Characterization of the monocyte-specific esterase (MSE) gene Leukemia 1994; 8: 1510-1526.
86. Drexler HG, Gignac SM, Minowada J. Hematopoietic cell lines. In: Hay RJ, Park JG, Gazdar A (eds). Atlas of Human Tumor Cell Lines. Academic Press: Orlando, 1994, pp 213-250.
87. Hassan HT, Drexler HG. Interleukins and colony stimulating factors in human myeloid leukemia cell lines. Leuk Lymphoma 1995; 20: 1-15.
88. Drexler HG. Leukemia cell lines: in vitro models for the study of chronic myeloid leukemia. Leuk Res 1994; 18: 919-927.
89. Drexler HG, MacLeod RAF, Borkhardt A, Janssen JWG. Recurrent chromosomal translocations and fusion genes in leukemia-lymphoma cell lines. Leukemia 1995; 9: 480-500
90. Drexler HG, Dirks W, MacLeod RAF, Quentmeier H, Steube K (eds). DSM Catalogue of Human and Animal Cell Lines, 5th edn. Braunschweig, Germany, 1995.
91. Quentmeier H, Zaborski M, Graf G, Ludwig WD, Drexler HG. Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cells. Leukemia 1996; 10: 297-310.
92. Freedman MH, Grunberger T, Correa P, Axelrad AA, Dube ID, Cohen A. Autocrine and paracrine growth control by granulocyte-monocyte colony-stimulating factor of acute lymphoblastic leukemia cells. Blood 1993; 81. 3068-3075.
93. Pietsch T. Paracrine and autocrine growth mechanisms of human stem cell factor (c-kit ligand) in myeloid leukemia. Nouv Rev Fr Hematol 1993; 35: 285-286.
94. Rogers SY, Bradbury D, Kozlowski R, Russel NH. Evidence for internal autocrine regulation of growth in acute myeloblastic leukemic cells. Exp Hematol 1994; 22: 593-598.
95. Vellenga E, Ostapovicz D, O'Rourke B, Griffin JD. Effects of recombinant IL-3, GM-CSF, and G-CSF on the proliferation of leukemic clonogenic cells in short-term and long-term cultures. Leukemia 1987; 1: 584-588.
96. Miyauchi J, Kelleher CA, Yang YC, Wong GG, Clark SC, Minden MD, Minkin S, McCulloch EA. The effects of three recombinant growth factors, IL-2, GM-CSF and G-CSF, on the blast cells of acute myeloblastic leukemia maintained in short-term suspension culture. Blood 1987; 70: 657-663.
97. Metcalf D. Role of hemopoietic growth factors in the development and suppression of myeloid leukemia. Leukemia 1992; 6 (Suppl. 3): 187S-188S.
98. Mirro J Jr, Hurwitz CA, Behm FG, Head DR, Raimondi SC, Crist WM, Ihle JN. Effects of recombinant human hematopoietic growth factors on leukemic blasts from children with acute myeloblastic or lymphoblastic leukemia. Leukemia 1993; 7: 1026-1033.
99. Ikeda H, Kanakura Y, Tamaki T, Kuriu A, Kitayama H, Ishikawa J, Kanayama Y, Yonezawa T, Tarui S, Griffin JD. Expression and functional role of the proto-oncogene c-kit in acute myeloblastic cells. Blood 1991; 78: 2962-2968.
100. Pietsch T, Kyas U, Steffens U, Yakisan E, Hadam MR, Ludwig WD, Zsebo K, Welte K. Effects of human stem cell factor (c-kit ligand) on proliferation of myeloid leukemia cells: heterogeneity in response and synergy with other hematopoietic growth factors Blood 1992; 80: 1199-1206.
101. Budel LM, Delwel R, Buitenen CV, Hoogerbrugge H, lowenberg B. Effects of mast cell growth factor on acute myeloid leukemia cells in vitro: effects of combinations with other cytokines. Leukemia 1993; 7: 426-434.
102. Matsumura I, Kanakura Y, Kato T, Ikeda H, Ishikawa J, Horikawa Y, Hashimoto K, Moriyama Y, Tsujimura T, Nishiura T, Miyazaki H, Matsuzawa Y.Growth response of acute myeloblastic leukemia cells to recombinant human thrombopoietin. Blood 1995; 86: 703-709.
103. Nara N, Kurokawa H, Tohda S, Torniyama J, Nagata K, Tanikawa S. The effect of basic and acidic fibroblast growth factors (bFGF and aFGF) on the growth of leukemic blast progenitors in acute myelogenous leukemia. Exp Hematol 1995; 23: 1030-1034.
104. Foa R, Caretto P, Fierro MT, Bonferroni M, Cardona S, Guarini A, Lista P, Pegoraro L, Mandelli F, Forni G, Gavosto F. Interleukin 2 does not promote the in vitro and in vivo proliferation and growth of human acute leukaemia cells of myeloid and lymphoid origin. Br J Haematol 1990; 75: 34-40.
105. Makrynikola V, Kabral A, Bradstock K. Effects of interleukin-7 on the growth of clonogenic cells in T-cell acute lymphoblastic leukaemia. Leuk Res 1991; 15: 879-882.
106. Masuda M, Hoshino S, Motoji T, Oshimi K, Mizoguchi H. Effects of various cytokines on proliferation of acute lymphoblastic leukemia cells. Leuk Res 1990; 14: 533-543.
107. Masuda M, Motoji T, Oshimi K, Mizoguchi H. Interleukin-7 and its effects on leukemia and lymphoma cells. Leuk Lymphoma 1991; 5: 231-236.
108. Skjonsberg C, Erikstein BK, Smeland SB, Lie SO, Funderud S, Beiske K, Blomhoff HK. Interleukin-7 differentiates a subgroup of acute lymphoblastic leukemias. Blood 1991; 77: 2445-2450.
109. Touw I, Delwel R, van Zanen G, Löwenberg B. Acute lymphoblastic leukemia and non-Hodgkin's lymphoma of T lineage: colony forming cells retain growth factor (interleukin 2) dependence Blood 1986; 68: 1088-1094.
110. Touw I, Pouwels K, van Agthoven T, van Gurp R, Budel L, Hoogerbrugge H, Delwel R, Goodwin R, Namen A, Löwenberg B. Interleukin-7 is a growth factor of precursor B and T acute lymphoblastic leukemia. Blood 1990; 75: 2097-2101.
111. Touw I, Groot-Loonen J, Breeders L, van Agthoven T, Hahlen K, Hagemeijer A, Löwenberg B. Recombinant hematopoietic growth factors fail to induce a proliferative response in precursor B acute lymphoblastic leukemia. Leukemia 1989; 3: 356-362.
112. Wörmann B, Gesner TG, Mufson RA, LeBien TW Proliferative effect of interleukin-3 on normal and leukemic human B cell precursors. Leukemia 1989; 3: 399-404.
113. Eder M, Ottmann OG, Hansen-Hagge TE, Bartram CR, Gillis S, Hoelzer D, Ganser A. Effects of recombinant human IL-7 on blast cell proliferation in acute lymphoblastic leukemia. Leukemia 1990; 4: 533-540.
114. Eder M, Ottmann OG, Hansen-Hagge TE, Bartram CR, Falk S. Gillis S, Hoelzer D, Ganser A. In vitro culture of common acute lymphoblastic leukemia blasts: effects of interleukin-3, interleukin-7, and accessory cells. Blood 1992; 79: 3274-3284.
115. Zola H, Siderius N, Flego L, Beckman I, Seshadri R. Cytokine receptor expression in leukemic cells. Leuk Res 1994; 18: 347-355.
116. Lisovsky M, Estrov Z, Consoli U, Munker R, Andreeff M FLT3 ligand stimulates proliferation and inhibits apoptosis of acute myeloid leukemia blasts. Blood 1995; 86: 22a.
117. Jansen JH, Wientjens GJHM, Fibbe WE, Willemze R, Kluin-Nelemans HC. Inhibition of human macrophage colony formation by interleukin-4. J Exp Med 1989; 170: 577-582.
118. Jansen JH, Fibbe WE, Wientjens GJHM, Willemze R, Kluin-Nelemans JC. Inhibitory effect of interleukin-4 on the proliferation of acute myeloid leukemia cells with myelo-monocytic differentiation (AML-M4/M5). The role of interleukin-6. Leukemia 1993; 7: 643-645.